They are the big dogs of modern mergers and acquisitions (M&As) — rapacious dealmakers that have devoured mighty corporations, bankrolled young disrupters and upended entire industries. And they are not looking so tough anymore.
Since 2014, when the latest wave of mergers and acquisitions began to build, three names have inspired fear and envy in the M&A world. In doing so, each has been totemic of a particular vogue in the capital markets:
3G Capital, the Brazilian investment firm that has picked off some of the US’ most famous brands and aggressively squeezed out costs and jobs; Valeant Pharmaceuticals, the ill-fated Canadian company that gobbled up drugmakers, drove up prices and fueled outrage over high prescription costs; and Softbank Group Corp, the big-dreaming — and big-spending — Japanese conglomerate that has backed the likes of Uber Technologies Inc and WeWork and remains one of the most powerful forces in Silicon Valley.
Photo: AP
From the start, the three M&A powerhouses adopted wildly different strategies.
However, for any investor, the similarities deserve attention. Wall Street believed them and their many imitators to be exceptional. Turns out, they were not, and are not.
That is worth remembering at a moment when financial world is struggling to come to grips with the yawning gap between what the pros think companies are worth and what those companies actually fetch on public markets — see WeWork’s botched initial public offering.
Not long ago, 3G, cofounded by billionaire Jorge Paulo Lemann, seemed unstoppable. Lemann became a global name by cobbling together the world’s biggest beermaker, Anheuser-Busch InBev; picking up brands like Burger King and Tim Hortons; and driving the 2015 merger between Kraft and Heinz to create one of world’s largest food companies.
3G has since stumbled — hard. Mixing Kraft Foods Inc and HJ Heinz Co turned out to be a disastrous idea, and not just for those two companies.
The investment firm’s usual combine-and-cut formula failed miserably at Kraft Heinz Co.
Since Lemann teamed up with none other than Warren Buffett to do the deal, sales and profits have tanked. 3G’s dream of turning Kraft Heinz into the savior of Big Food ended when Unilever rebuffed its US$143 billion takeover offer in 2017.
In February, Kraft Heinz took a staggering US$15.4 billion writedown. The company’s stock has plunged more than 70 percent from its peak, helping to drag down rivals like Kellogg Co, Campbell Soup Co and General Mills Inc.
Former management consultant Michael Pearson had a similarly radical idea at Valeant: that drugmakers like itself had no business actually making drugs.
Instead, it would borrow money to acquire rivals, dramatically increase the price of their treatments and fire almost everyone. Rinse, repeat.
Valeant’s ambition peaked in 2014, when it teamed up with activist investor Bill Ackman to mount an audacious US$54 billion takeover offer for Allergan PLC, the maker of Botox.
The bid was spurned, but Ackman and Pearson were undimmed and, as if to prove their theory, took the company on a buying spree that included gastrointestinal drugmaker Salix Pharmaceuticals Inc (US$11.1 billion) and Sprout Pharmaceuticals Inc, a developer of female libido stimulants (US$1 billion).
For a while investors approved, sending Valeant’s market value to US$90 billion in August 2015. Then things went spectacularly wrong.
Accounting irregularities, mounting debts and political angst over surging drug prices destroyed not only the Valeant dream, but those of the entire specialty pharmaceuticals industry.
Shares of Valeant are 93 percent lower, with a new management, board and shareholder base, and has renamed itself Bausch Health Companies Inc.
There is no nice way to bring Softbank into this part of the story.
By almost any conceivable measure, it is having a diabolical year. The quixotic Masayoshi Son, a start-up kingmaker of undoubted brilliance, has staked Softbank’s billions — and its reputation — on three companies: Uber, the ride-hailing app which has lost about a third of its value, or US$19 billion, since its May IPO; Slack, a messaging platform, which debuted in June and is down 35 percent from where it ended its first trading day; and WeWork.
The scale of these blowups, so starkly at odds with Softbank’s recent esteemed status, has dislocated the US IPO markets as investors and would-be public companies look skeptically at one another across a widening gulf of value perception.
In hindsight, the impermanence of the three dealmakers’ strategies is easy to skewer.
However, the success of 3G and Valeant was fueled by some of the most well-known names in finance. Softbank, meanwhile, tapped entire nations to bankroll its ambitions of creating a future of robot-human harmony.
These failures could end up restricting Son’s access to funding, but it is unlikely to diminish his vision for what he has said is a 300-year plan to grow the company he started 38 years ago.
Nor, probably, will it dampen his enthusiasm for what he has called the gold rush of investing in nascent technology.
“It’s just a money thing. It’s not important, it’s just a process. What is more important is humans’ happiness? How do we help ourselves, humans, become happier?” Son said in 2017, calling himself a “super optimist.”
“There’s always a solution,” he said.
What is more likely is the end of the burgeoning trend of taking loss-making companies public in the hope the future will come to them.
Perhaps, too, some doubt will attach itself to the idea that pumping a young business with money and expecting it to succeed is not an idea of wheel-inventing novelty.
Either way, there will be something else to worship soon enough. There always is.
Taiwan’s foreign exchange reserves fell below the US$600 billion mark at the end of last month, with the central bank reporting a total of US$596.89 billion — a decline of US$8.6 billion from February — ending a three-month streak of increases. The central bank attributed the drop to a combination of factors such as outflows by foreign institutional investors, currency fluctuations and its own market interventions. “The large-scale outflows disrupted the balance of supply and demand in the foreign exchange market, prompting the central bank to intervene repeatedly by selling US dollars to stabilize the local currency,” Department of Foreign
ENERGY ISSUES: The TSIA urged the government to increase natural gas and helium reserves to reduce the impact of the Middle East war on semiconductor supply stability Chip testing and packaging service provider ASE Technology Holding Co (日月光投控) yesterday said it planned to invest more than NT$100 billion (US$3.15 billion) in building a new advanced chip testing facility in Kaohsiung to keep up with customer demand driven by the artificial intelligence (AI) boom. That would be included in the company’s capital expenditure budget next year, ASE said. There is also room to raise this year’s capital spending budget from a record-high US$7 billion estimated three months ago, it added. ASE would have six factories under construction this year, another record-breaking number, ASE chief operating officer Tien Wu
The EU and US are nearing an agreement to coordinate on producing and securing critical minerals, part of a push to break reliance on Chinese supplies. The potential deal would create incentives, such as minimum prices, that could advantage non-Chinese suppliers, according to a draft of an “action plan” seen by Bloomberg. The EU and US would also cooperate on standards, investments and joint projects, as well as coordinate on any supply disruptions by countries like China. The two sides are additionally seeking other “like-minded partners” to join a multicountry accord to help create these new critical mineral supply chains, which feed into
For weeks now, the global tech industry has been waiting for a major artificial intelligence (AI) launch from DeepSeek (深度求索), seen as a benchmark for China’s progress in the fast-moving field. More than a year has passed since the start-up put Chinese AI on the map in early last year with a low-cost chatbot that performed at a similar level to US rivals. However, despite reports and rumors about its imminent release, DeepSeek’s next-generation “V4” model is nowhere in sight. Speculation is also swirling over the geopolitical implications of which computer chips were chosen to train and power the new